drugset / Trial / NCT01901341
The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of CB-5945 for the treatment of opioid-induced constipation (OIC) in adults taking opioid therapy for chronic non-cancer pain.
Timeline
- Start
- 2013-07-02
- Primary completion
- 2014-02-13
- Completion
- 2014-02-13
Outcome
Outcome not reported
Stopped (Enrollment): “Due to difficulties with enrollment, the study was terminated early.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bevenopran | Small molecule | 0.25 mg | Oral |